All Stories

  1. An analysis of biologically active additives in the form of fat-soluble vitamins in the territory of the Russian Federation
  2. Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis
  3. A brief survey of interventional agents intended to treat Long COVID
  4. Dysregulation of tyrosinase activity: a potential link between skin disorders and neurodegeneration
  5. What is the place of naturalistic philosophy in the doing of science? Implications for the teaching of science
  6. The Climate Fix: make what’s important measurable …
  7. In the doing of science, what is the place for naturalistic philosophy? Implications for the teaching of science
  8. Occupation from a perspective of complementarity - Part 2 - Proposals for situating a complementarity perspective in occupational science
  9. Occupation from a perspective of complementarity - Part 1 - Background to the development of a concept
  10. Occupation from a perspective of complementarity - Part 2 - Proposals for situating a complementarity perspective in occupational science
  11. A preliminary investigation of what occupational science is doing
  12. Restoring Australia’s long-term innovation requires investment in basic research
  13. On the ongoing need for naturalistic philosophy to interpret what occupational science is doing
  14. “We Ourselves Are Both Actors and Spectators”: What is the Place of Naturalistic Philosophy in the Doing of Science? Implications for the Teaching of Science
  15. Review of: "Naturalism's maxims and its methods. Is naturalistic philosophy like science?"
  16. “Elements of My Life”
  17. Risk Factors for Heart Disease in Working Railwaymen
  18. Engineering indel and substitution variants of diverse and ancient enzymes using Graphical Representation of Ancestral Sequence Predictions (GRASP)
  19. Cat in Trinity Lane, Cambridge, 2010
  20. A Pair of Floating Microscopes: Transformation by Reflection
  21. A Left-Handed Pillar Box
  22. Antiinflammatory and Anticancer Properties of Grewia asiatica Crude Extracts and Fractions: A Bioassay-Guided Approach
  23. Lunar Eclipse, May 26, 2021
  24. Phytochemical Profile, Biological Properties, and Food Applications of the Medicinal Plant Syzygium cumini
  25. The Chemical Composition and Health-Promoting Effects of the Grewia Species—A Systematic Review and Meta-Analysis
  26. From Engineer to Artist: “Who Is the Potter, Pray, and Who the Pot?”
  27. Kookaburras on the Clothes Line, Backyard, Queensland
  28. In silico molecular dynamics of human glycophorin A (GPA) extracellular structure
  29. Syzygium cumini(L.),Skeels fruit extracts: In vitro and in vivo anti-inflammatory properties
  30. The interaction between Glycophorin A (GPA) and Band 3 in the formation of the Wright b (Wrb) antigen
  31. Tyrosinase inhibitors as potential antibacterial agents
  32. Hydroxyl substituted benzoic acid/cinnamic acid derivatives: Tyrosinase inhibitory kinetics, anti-melanogenic activity and molecular docking studies
  33. Editorial
  34. From Generation to Generation
  35. The Zone of Inhibition
  36. Serendipity in Science: The Unexpected Tie
  37. Discrimination and Social Justice: Questions of Diversity, Plurality, Representativeness, Measurability, and Doublespeak
  38. The Bay of Marseille, Viewed from L'Estaque, 2010
  39. Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007–2017)
  40. “Baby” Microscope
  41. Nicotiana tabacum, or the Letter “Aleph” with 22 Flowers
  42. Precision Medicines Have Faster Approvals Based On Fewer And Smaller Trials Than Other Medicines
  43. A Shark–Human Chimera
  44. Development of a Multiplexed Microsphere PCR for Culture-Free Detection and Gram-Typing of Bacteria in Human Blood Samples
  45. Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins
  46. Human Blood CD1c+ Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4+ T Cells
  47. A New Clade of Insect-Specific Flaviviruses from Australian Anopheles Mosquitoes Displays Species-Specific Host Restriction
  48. Characterization of the banana streak virus capsid protein and mapping of the immunodominant continuous B-cell epitopes to the surface-exposed N terminus
  49. Permeation of topically applied Magnesium ions through human skin is facilitated by hair follicles
  50. A New Orbivirus Isolated from Mosquitoes in North-Western Australia Shows Antigenic and Genetic Similarity to Corriparta Virus but Does Not Replicate in Vertebrate Cells
  51. CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses
  52. Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia
  53. Commensal Viruses of Mosquitoes: Host Restriction, Transmission, and Interaction with Arboviral Pathogens
  54. The Tortoise and the Hare: Evolving Regulatory Landscapes for Biosimilars
  55. A novel insect-specific flavivirus replicates only in Aedes-derived cells and persists at high prevalence in wild Aedes vigilax populations in Sydney, Australia
  56. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation
  57. RNA and DNA Diagnostics on Microspheres: Current and Emerging Methods
  58. Genotyping of Campylobacter jejuni using a novel Polymerase-Chain-Reaction-Microsphere approach
  59. Application of the PrimRglo Assay Chemistry to Multiplexed Bead Assays
  60. Effects of magnesium deficiency – More than skin deep
  61. Multi-locus sequence typing of Campylobacter jejuni using a novel polymerase-chain-reaction-microsphere method
  62. Interdisciplinary science research and education
  63. Gene expression phenotypes for lipid metabolism and intramuscular fat in skeletal muscle of cattle1
  64. A New, Multiplex, Quantitative Real-Time Polymerase Chain Reaction System for Nucleic Acid Detection and Quantification
  65. Multiplex–microsphere–quantitative polymerase chain reaction: Nucleic acid amplification and detection on microspheres
  66. Recombinant Vaccines: Development, Production, and Application
  67. PrimRglo: A multiplexable quantitative real-time polymerase chain reaction system for nucleic acid detection
  68. Chronic exposure to anabolic steroids induces the muscle expression of oxytocin and a more than fiftyfold increase in circulating oxytocin in cattle
  69. Expecting the unexpected: nucleic acid-based diagnosis and discovery of emerging viruses
  70. Chapter 2 Complexity and mastery in shaping interdisciplinarity
  71. Molecular Phylogeny of Edge Hill Virus Supports its Position in the Yellow Fever Virus Group and Identifies a New Genetic Variant
  72. Recombinant vaccines
  73. A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies
  74. Detection of Influenza A Virus Neuraminidase and PB2 Gene Segments by One Step Reverse Transcription Polymerase Chain Reaction
  75. University biotechnology education in Australia in an international context
  76. A broad spectrum, one-step reverse-transcription PCR amplification of the neuraminidase gene from multiple subtypes of influenza A virus
  77. Genomic characterisation of Wongabel virus reveals novel genes within the Rhabdoviridae
  78. Universal primers that amplify RNA from all three flavivirus subgroups
  79. Interdisciplinarity and Interprofessionalism: Implications for Biotechnology Education
  80. Use of Chimeric Antibodies as Positive Controls in an Enzyme-Linked Immunosorbent Assay for Diagnosis of Scrub Typhus (Infection by Orientia tsutsugamushi)
  81. Reply to Herrera and Ruiz-Opazo's letter published in the June 2006 issue
  82. A1079T transversion in the gene for the α1 isophorm of the Na+/K+ ATPase in the Dahl S rat
  83. Development of an Oligonucleotide-Based SNP Detection Method on Lateral Flow Strips Using Hexapet Tags
  84. Chimerization of multiple antibody classes using splice overlap extension PCR
  85. The ''parallel bridge'' and its relevance to biotechnology new ventures
  86. Towards definition of the global biotechnology value chain using cases from Australian biotechnology SMEs
  87. Valuing of firms' prior knowledge: a measure of knowledge distance
  88. Arsenic inhibits the repair of DNA damage induced by benzo(a)pyrene
  89. GH Treatment in Adults with Chronic Liver Disease: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study
  90. Placental Growth Hormone Is Not Suppressed by Oral Glucose Loading in Normal Human Pregnancy
  91. Neither the New Zealand Genetically Hypertensive Strain nor Dahl Salt-Sensitive Strain Has an A1079T Transversion in the α1 Isoform of the Na + ,K + -ATPase Gene
  92. Growth hormone binding protein in normal and aneuploid pregnancy: a paradoxical decrease in trisomy 18
  93. Growth hormone binding protein in normal and aneuploid pregnancy: a paradoxical decrease in trisomy 18
  94. Comparison of Competitively Primed and Conventional Allele-Specific Nucleic Acid Amplification
  95. Placental Growth Hormone (GH), GH-Binding Protein, and Insulin-Like Growth Factor Axis in Normal, Growth-Retarded, and Diabetic Pregnancies: Correlations with Fetal Growth
  96. True
  97. Administration of growth hormone or IGF-I to pregnant rats on a reduced diet throughout pregnancy does not prevent fetal intrauterine growth retardation and elevated blood pressure in adult offspring
  98. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure
  99. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response
  100. Analysis and Application of an Equilibrium Model forin vitroBioassay Systems with Three Components: Receptor, Hormone and Hormone-Binding-Protein
  101. Expression of Growth Hormone Receptors by Lymphocyte subpopulations in the Human tonsil
  102. Growth Hormone-Binding Protein in Normal and Pathologic Gestation: Correlations with Maternal Diabetes and Fetal Growth1
  103. Functional growth hormone (GH) receptors and GH are expressed by preimplantation mouse embryos: A role for GH in early embryogenesis?
  104. The serum growth hormone binding protein: pregnant with possibilities
  105. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems
  106. Upregulation of GH receptor and GH binding protein during pregnancy in the GH deficient rat
  107. A Growth Hormone Agonist Produced by Targeted Mutagenesis at Binding Site 1.
  108. Measurement of growth hormone-binding protein in the rat by a ligand immunofunctional assay
  109. Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor.
  110. Evidence for Involvement of the Carboxy Terminus of Helix 1 of Growth Hormone in Receptor Binding: Use of Charge Reversal Mutagenesis to Account for Calcium Dependence of Binding and for Design of Higher Affinity Analogs
  111. Selective inhibition of mouse placental lactogen II secretion by tumour necrosis factor-α
  112. Signal Transduction by the Growth Hormone Receptor
  113. The search for receptor-interactive regions in growth hormone: historical perspectives and novel strategies
  114. Expression of growth hormone-binding protein with a hydrophilic carboxyl terminus by the mouse placenta: studies in vivo and in vitro
  115. Growth hormone receptor and growth hormone-binding protein messages in mouse placenta contain the exon analogous to human exon 3
  116. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system
  117. A strategy for optimizing charge reversal mutagenesis of ion pairs in hormone—receptor or enzyme—substrate complexes
  118. The first disulphide loop of the rabbit growth hormone receptor is required for binding to the hormone
  119. Expression of the growth hormone receptor and growth hormone-binding protein during pregnancy in the mouse
  120. A mouse growth hormone-binding protein RIA: concentrations in maternal serum during pregnancy.
  121. Growth Hormone (GH) Receptors in Clonal Osteoblast Like Cells Mediate a Mitogenic Response to GH*
  122. Visual Demonstration of Growth Hormone Receptors on Human Growth Plate Chondrocytes*
  123. Soluble forms of the rabbit adipose tissue and liver growth hormone receptors are antigenically identical, but the integral membrane forms differ
  124. Characterization of the growth hormone-binding protein of human serum using a panel of monoclonal antibodies
  125. An electrostatic model for the interaction between growth hormone and its receptor involving chelation of Ca2+ to the human growth hormone molecule
  126. The Ontogeny of Growth Hormone Receptors in the Rabbit Tibia*
  127. Use of calcium dependence as a means to study the interaction between growth hormones and their binding proteins in rabbit liver
  128. Growth hormone receptor and serum binding protein: purification, cloning and expression
  129. Serum and liver cytosolic growth-hormone-binding proteins are antigenically identical with liver membrane ‘receptor’ types 1 and 2
  130. Evidence for Differential Binding of Growth Hormones to Membrane and Cytosolic GH Binding Proteins of Rabbit Liver
  131. Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor
  132. Monoclonal Antibodies to the Rabbit Liver Growth Hormone Receptor: Production and Characterization*
  133. Use of serum copper/zinc ratio in patients with large bowel cancer
  134. Tennessee antigen
  135. Tennessee antigen
  136. Serum glycoproteins in diagnosis and monitoring of patients with large-bowel cancer
  137. VALUE OF SERIAL CARCINOEMBRYONIC ANTIGEN DETERMINATIONS FOR EARLY DETECTION OF RECURRENT CANCER
  138. Diagnostics development for clinical and research settings